(EU) 2015/8:拒绝批准某些食品健康声称,不涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health)

【发布单位】 EUROPEAN COMMISSION 
【发布文号】 (EU) 2015/8
【发布日期】 2015-01-07
【生效日期】 
【废止日期】 
【替代法规】 
【效  力】 
【食品伙伴网解读】 2015年1月7日,欧盟发布委员会条例(EU) 2015/8,拒绝批准5种食品健康声称,分别如下:1)葡萄糖:机体正常能量代谢时分解葡萄糖;2)葡萄糖可维持正常的体力活动;3)葡萄糖有助于正常的产能代谢;4)葡萄糖有助于运动过程中正常的产能代谢;5)葡萄糖有助于正常的肌肉功能。
—————————————————————————————————————————————————————————————

  COMMISSION REGULATION (EU) 2015/8

  of 6 January 2015

  refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health

  (Text with EEA relevance)

  THE EUROPEAN COMMISSION,

  Having regard to the Treaty on the Functioning of the European Union,

  Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular Article 18(4) thereof,

  Whereas:

  (1)

  Regulation (EC) No 1924/2006 provides that health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.

  (2)

  Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims are to be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’, for a scientific assessment, as well as to the Commission and the Member States for information.

  (3)

  The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority. In some cases, the scientific risk assessment alone cannot provide all the information on which a risk management decision should be based and therefore other legitimate factors relevant to the matter under consideration should also be taken into account.

  (4)

  Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00266) (2). The claim proposed by the applicant was worded as follows: ‘Glucose is metabolised within body's normal energy metabolism’.

  (5)

  On 11 May 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that on the basis of the data presented, a cause and effect relationship had been established between the consumption of glucose and contribution to energy-yielding metabolism. The target population is the general population.

  (6)

  Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00267) (3). The claim proposed by the applicant was worded as follows: ‘Glucose supports normal physical activity’.

  (7)

  On 11 May 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that a claim on glucose and contribution to energy-yielding metabolism has already been assessed with a favourable outcome and referred to its opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00266).

  (8)

  Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00268) (4). The claim proposed by the applicant was worded as follows: ‘Glucose contributes to normal energy-yielding metabolism’.

  (9)

  On 11 May 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that a claim on glucose and contribution to energy-yielding metabolism has already been assessed with a favourable outcome and referred to its opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00266).

  (10)

  Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00269) (5). The claim proposed by the applicant was worded as follows: ‘Glucose contributes to normal energy-yielding metabolism during exercise’.

  (11)

  On 11 May 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that a claim on glucose and contribution to energy-yielding metabolism has already been assessed with a favourable outcome and referred to its opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00266).

  (12)

  Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00270) (6). The claim proposed by the applicant was worded as follows: ‘Glucose contributes to normal muscle function’.

  (13)

  On 11 May 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that a claim on glucose and contribution to energy-yielding metabolism has already been assessed with a favourable outcome and referred to its opinion on a health claim related to glucose and contribution to energy-yielding metabolism (Question No EFSA-Q-2012-00266).

  (14)

  Pursuant to Articles 6(1) and 13(1) of Regulation (EC) No 1924/2006 health claims need to be based on generally accepted scientific evidence. Authorisation may also legitimately be withheld if health claims do not comply with other general and specific requirements of Regulation (EC) No 1924/2006, even in the case of a favourable scientific assessment by the Authority. Health claims inconsistent with generally accepted nutrition and health principles should not be made. The Authority concluded that a cause and effect relationship has been established between the consumption of glucose and contribution to energy-yielding metabolism. However, the use of such a health claim would convey a conflicting and confusing message to consumers, because it would encourage consumption of sugars for which, on the basis of generally accepted scientific advice, national and international authorities inform the consumer that their intake should be reduced. Therefore, such a health claim does not comply with point (a) of the second paragraph of Article 3 of Regulation (EC) No 1924/2006 which foresees that the use of claims should not be ambiguous or misleading. Furthermore, even if the concerned health claim was to be authorised only under specific conditions of use and/or accompanied by additional statements or warnings, it would not be sufficient to alleviate the confusion of the consumer, and consequently the claim should not be authorised.

  (15)

  The health claims covered by this Regulation are health claims as referred to in Article 13(1)(a) of Regulation (EC) No 1924/2006, which, provided that they comply with that Regulation, are subject to the transitional period laid down in Article 28(5) of that Regulation until the adoption of the list of permitted health claims.

  (16)

  The list of permitted health claims has been established by Commission Regulation (EU) No 432/2012 (7) and is applicable since 14 December 2012. As regards claims referred to in Article 13(5) of Regulation (EC) No 1924/2006 for which the evaluation by the Authority or consideration by the Commission has not been completed by 14 December 2012 and which by virtue of this Regulation are not included in the list of permitted health claims, it is appropriate to provide for a transitional period during which they may still be used, in order to allow both food business operators and the competent national authorities to adapt to the prohibition of such claims.

  (17)

  The comments from the applicant and the members of the public received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.

  (18)

  The Member States have been consulted,

  HAS ADOPTED THIS REGULATION:

  Article 1

  1.   The health claims set out in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

  2.   However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation, may continue to be used for a maximum period of six months after the entry into force of this Regulation.

  Article 2

  This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

  This Regulation shall be binding in its entirety and directly applicable in all Member States.

  Done at Brussels, 6 January 2015.

  For the Commission

  The President

  Jean-Claude JUNCKER
 

ANNEX
Rejected health claims
Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Glucose
Glucose is metabolised within body's normal energy metabolism
Q-2012-00266
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Glucose
Glucose supports normal physical activity
Q-2012-00267
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Glucose
Glucose contributes to normal energy-yielding metabolism
Q-2012-00268
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Glucose
Glucose contributes to normal energy-yielding metabolism during exercise
Q-2012-00269
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Glucose
Glucose contributes to normal muscle function
Q-2012-00270

 

联系我们


  • 电话: 0571-87007538
  • 传真: 0571-87007566
  • 地址: 杭州市文一西路1288号海创科技中心3号楼14层 (311121) 
你目前位置: Home 食品国外法规 (EU) 2015/8:拒绝批准某些食品健康声称,不涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health)